Recent papers
(click on journal logo to download, click on
to get citations)
(click on journal logo to download, click on
2012-107
Schaefer M, Sarkar R, Weich V, Effenberger S, Friebe A, Heinze L, Spengler U, Schlaepfer T, Reimer J, Buggisch P, Ockenga J, Link R, Rentrop M, Weidenbach H, Discher T, Fromm G, Lieb K, Baumert T, Heinz A, Zeuzem S, Berg T (2010): Escitalopram for the Prevention of Peginterferon Alfa-2a and Ribavirin Associated Depression in HCV-infected patients. Annals of Internal Medicine 157:94-103.
Schaefer M, Sarkar R, Weich V, Effenberger S, Friebe A, Heinze L, Spengler U, Schlaepfer T, Reimer J, Buggisch P, Ockenga J, Link R, Rentrop M, Weidenbach H, Discher T, Fromm G, Lieb K, Baumert T, Heinz A, Zeuzem S, Berg T (2010): Escitalopram for the Prevention of Peginterferon Alfa-2a and Ribavirin Associated Depression in HCV-infected patients. Annals of Internal Medicine 157:94-103.
2012-111
Bewernick B, Kayser S, Sturm V, Schlaepfer TE (2012): Long-Term Effects of Nucleus Accumbens Deep Brain Stimulation in Treatment-Resistant Depression: Evidence for Sustained Efficacy. Neuropschopharmacology doi:10.1038/npp.2012.44.
Bewernick B, Kayser S, Sturm V, Schlaepfer TE (2012): Long-Term Effects of Nucleus Accumbens Deep Brain Stimulation in Treatment-Resistant Depression: Evidence for Sustained Efficacy. Neuropschopharmacology doi:10.1038/npp.2012.44.
2011-109
Goodwin G, Abbar M, Schlaepfer TE, Grunze H, Licht R, Belevier F, Fountoulakis K, Altamura C, Pitchot W, Agren H, Holsboer-Trachsler E, Vieta E (2011): Aripiprazole in Patients with Bipolar Disorder and Beyond: An Update of Practical Guidance. Current Medical Research & Opinion [Epub ahead of print].
Goodwin G, Abbar M, Schlaepfer TE, Grunze H, Licht R, Belevier F, Fountoulakis K, Altamura C, Pitchot W, Agren H, Holsboer-Trachsler E, Vieta E (2011): Aripiprazole in Patients with Bipolar Disorder and Beyond: An Update of Practical Guidance. Current Medical Research & Opinion [Epub ahead of print].
2011-103
Schlaepfer TE, Saviane C (2011): Special Topic: The development of deep brain stimulation for neurological and psychiatric disorders: clinical, societal and ethical issues. Frontiers in Integrative Neuroscience 5.
Link: Frontiers in Integrative Neuroscience | Special Topics
Schlaepfer TE, Saviane C (2011): Special Topic: The development of deep brain stimulation for neurological and psychiatric disorders: clinical, societal and ethical issues. Frontiers in Integrative Neuroscience 5.
Link: Frontiers in Integrative Neuroscience | Special Topics
2011-097
Wade AG, Crawford GM, Nemeroff CB, Schatzberg AF, Schlaepfer T, McConnachie A, Haazen L, Buntinx E (2011): Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response. Psychological Medicine 41:2089-97.
Wade AG, Crawford GM, Nemeroff CB, Schatzberg AF, Schlaepfer T, McConnachie A, Haazen L, Buntinx E (2011): Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response. Psychological Medicine 41:2089-97.
2010-075
Bewernick BH, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B, Axmacher N, Lemke M, Cooper-Mahkorn D, Cohen MX, Brockmann H, Lenartz D, Sturm V, Schlaepfer TE (2010): Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 67:110-6
.
Bewernick BH, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B, Axmacher N, Lemke M, Cooper-Mahkorn D, Cohen MX, Brockmann H, Lenartz D, Sturm V, Schlaepfer TE (2010): Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 67:110-6
.


















